Abstract
Purpose. Drug targeting to activated endothelial cells is now being explored as a new approach to interfere with chronic inflammation. This study compares a dexamethasone-anti-E-selectin immunoconjugate (dexa-AbEsel) with anti-E-selectin immunoliposomes (AbEsel-immunoliposomes) that contain dexamethasone, regarding in vitro binding and internalization as well as in vivo accumulation in activated endothelial cells.
Methods. In vitro binding and internalization of dexa-AbEsel and the AbEsel-immunoliposomes into TNFα-activated HUVECs was studied using confocal laser scanning microscopy and radiolabeled compounds. Tissue accumulation of both compounds was studied in a murine delayed-type hypersensitivity model using immunohistochemistry.
Results and Conclusions. Both preparations were selectively internalized by activated endothelial cells. Dexa-AbEsel was internalized by activated HUVECs to a larger extent than the AbEsel-immuno- liposomes, although in theory the high drug-loading capacity of the liposomes may enable a larger amount of dexamethasone to be delivered intracellularly. Both dexa-AbEsel and AbEsel-immuno- liposomes accumulated in activated endothelial cells in murine inflamed skin. AbEsel-immunoliposomes, but not dexa-AbEsel, were additionally detected in control skin, though to a lesser extent, and in macrophages of the liver and the spleen. Studies on therapeutic effects and side effects in models of chronic inflammation are now necessary to establish pharmacodynamics of dexa-AbEsel and/or AbEsel-immunoliposomes in the treatment of chronic inflammation.
Similar content being viewed by others
REFERENCES
D. A. Steeber and T. F. Tedder. Adhesion molecule cascades direct lymphocyte recirculation and leukocyte migration during inflammation. Immunol. Res. 22:299-317 (2000).
M. Everts, A. J. Schraa, L. F. M. H. de Leij, D. K. F. Meijer, and G. Molema. Vascular endothelium in inflamed tissue as a target for site selective delivery of drugs. In G. Molema and D. K. F. Meijer (eds), Drug Targeting, Organ-Specific Strategies (G. Molema and D. K. F. Meijer, eds), Methods and principles in medicinal chemistry, Wiley-VCH, Weinheim, 2001, pp. 171-197.
M. P. Bevilacqua, S. Stengelin, M. A. Gimbrone, Jr., and B. Seed. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160-1165 (1989).
T. W. Kuijpers, M. Raleigh, T. Kavanagh, H. Janssen, J. Calafat, D. Roos, and J. M. Harlan. Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape. A tubulin-driven process. J. Immunol. 152:5060-5069 (1994).
D. D. Spragg, D. R. Alford, R. Greferath, C. E. Larsen, K. D. Lee, G. C. Gurtner, M. I. Cybulsky, P. F. Tosi, C. Nicolau, and M. A. Gimbrone. Immunotargeting of liposomes to activated vascular endothelial cells: A strategy for site-selective delivery in the cardiovascular system. Proc. Natl. Acad. Sci. USA 94:8795-8800 (1997).
G. Molema. Drug targeting: Basic concepts and novel advances. In G. Molema and D. K. F. Meijer (eds.), Drug Targeting. Organ-Specific Strategies. Wiley-VCH Verlag GmbH, Weinheim, 2001, pp. 1-22.
G. Storm and D. J. A. Crommelin. Liposomes: quo vadis? Pharm. Sci. Technol. To. 1:19-31 (1998).
E. Mastrobattista, G. A. Koning, and G. Storm. Immunoliposomes for the targeted delivery of antitumor drugs. Adv. Drug Deliv. Rev. 40:103-127 (1999).
D. L. Pierce, N. D. Heindel, K. J. Schray, M. M. Jetter, J. G. Emrich, and D. V. Woo. Misonidazole conjugates of the colorectal tumor associated monoclonal antibody 17-1A. Bioconjug. Chem. 1:314-318 (1990).
G. Stehle, H. Sinn, A. Wunder, H. H. Schrenk, S. Schutt, W. Maierborst, and D. L. Heene. The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats. Anticancer Drugs 8:677-685 (1997).
D. G. Covell, J. Barbet, O. D. Holton, C. D. V. Black, R. J. Parker, and J. N. Weinstein. Pharmacokinetics of monoclonal immunoglobulin G1, F(ab′)2, and Fab′ in mice. Cancer Res. 46:3969-3978 (1986).
D. K. F. Meijer and G. Molema. Targeting of drugs to the liver. Semin. Liver Dis. 15:202-256 (1995).
B. N. Melgert, P. Olinga, V. K. Jack, G. Molema, D. K. F. Meijer, and K. Poelstra. Dexamethasone coupled to albumin is selectively taken up by rat nonparenchymal liver cells and attenuates LPS-induced activation of hepatic cells. J. Hepatol. 32:603-611 (2000).
M. Everts, R. J. Kok, S. A. Asgeirsdottir, B. N. Melgert, T. J. Moolenaar, G. A. Koning, M. J. van Luyn, D. K. Meijer, and G. Molema. Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin-directed immunoconjugate. J. Immunol. 168:883-889 (2002).
A. D. McLeod, D. R. Friend, and T. N. Tozer. Synthesis and chemical stability of glucocorticoid-dextran esters: potential prodrugs for colon-specific delivery. Int. J. Pharm. 92:105-114 (1993).
G. A. Koning, H. W. Morselt, A. Gorter, T. M. Allen, S. Zalipsky, J. A. Kamps, and G. L. Scherphof. Pharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastases. Pharm. Res. 18:1291-1298 (2001).
G. Rouser, S. F. Keischer, and A. Yamamoto. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494-496 (1970).
E. G. Bligh and E. J. Dyer. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917 (1959).
G. L. Peterson. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83:346-356 (1977).
W. M. Hunter and F. C. Greenwood. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495-496 (1962).
D. C. Dahl, T. Tsao, W. C. Duckworth, M. J. Mahoney, and R. Rabkin. Retroendocytosis of insulin in a cultured kidney epithelial cell line. Am. J. Physiol. 257:C190-C196 (1989).
D. Kirpotin, J. W. Park, K. Hong, S. Zalipsky, W. L. Li, P. Carter, C. C. Benz, and D. Papahadjopoulos. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry 36:66-75 (1997).
U. Henseleit, K. Steinbrink, M. Goebeler, J. Roth, D. Vestweber, C. Sorg, and C. Sunderkotter. E-selectin expression in experimental models of inflammation in mice. J. Pathol. 180:317-325 (1996).
S. Kessner, A. Krause, U. Rothe, and G. Bendas. Investigation of the cellular uptake of E-selectin-targeted immunoliposomes by activated human endothelial cells. Biochim. Biophys. Acta 1514:177-190 (2001).
M. Yoshida, B. E. Szente, J. M. Kiely, A. Rosenzweig, and M. A. Gimbrone, Jr. Phosphorylation of the cytoplasmic domain of E-selectinis regulated during leukocyte-endothelial adhesion. J. Immunol. 161:933-941 (1998).
M. S. Kluger, S. L. Shiao, A. L. Bothwell, and J. S. Pober. Cutting edge: internalization of transduced E-selectin by cultured human endothelial cells: comparison of dermal microvascular and umbilical vein cells and identification of a phosphoserine-type di-leucine motif. J. Immunol. 168:2091-2095 (2002).
Y. Hu, B. Szente, J. M. Kiely, and M. A. Gimbrone, Jr. Molecular events in transmembrane signaling via E-selectin. SHP2 association, adaptor protein complex formation and ERK1/2 activation. J. Biol. Chem. 276:48549-48553 (2001).
R. R. Langley, J. Russell, M. J. Eppihimer, S. J. Alexander, M. Gerritsen, R. D. Specian, and D. N. Granger. Quantification of murine endothelial cell adhesion molecules in solid tumors. Am. J. Physiol. 277:H1156-H1166 (1999).
M. Lotem, A. Hubert, O. Lyass, M. A. Goldenhersh, A. Ingber, T. Peretz, and A. Gabizon. Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin. Arch. Dermatol. 136:1475-1480 (2000).
G. A. Koning, H. W. Morselt, J. A. A. M. Kamps, and G. L. Scherphof. Uptake and intracellular processing of PEG-liposomes and PEG-immunoliposomes by Kupffer cells in vitro. J. Liposome Res. 11:195-209 (2001).
G. A. Koning, R. M. Schiffelers, and G. Storm. Endothelial cells at inflammatory sites as target for therapeutic intervention. Endothelium 9:161-171 (2002).
J. Huwyler, D. Wu, and W. M. Pardridge. Brain drug delivery of small molecules using immunoliposomes. Proc. Natl. Acad. Sci. USA 93:14164-14169 (1996).
R. J. Kok, M. Everts, S. A. Ásgeirsdóttir, D. K. F. Meijer, and G. Molema. Cellular handling of a dexamethasone-anti-E-selectin immunoconjugate by activated endothelial cells: comparison with free dexamethasone. Pharm. Res. 19:1730-1735 (2002).
Author information
Authors and Affiliations
Corresponding author
Additional information
a network collaboration between the Universities of Groningen, Leiden, and Utrecht and the pharmaceutical company Yamanouchi
Rights and permissions
About this article
Cite this article
Everts, M., Koning, G.A., Kok, R.J. et al. In Vitro Cellular Handling and in Vivo Targeting of E-Selectin-Directed Immunoconjugates and Immunoliposomes Used for Drug Delivery to Inflamed Endothelium. Pharm Res 20, 64–72 (2003). https://doi.org/10.1023/A:1022298725165
Issue Date:
DOI: https://doi.org/10.1023/A:1022298725165